Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
UP FRONT MATTERSEditorials
You have accessRestricted Access

A New Approach to Idiopathic Nephrotic Syndrome

Joshua Y. Kausman and A. Richard Kitching
JASN October 2007, 18 (10) 2621-2622; DOI: https://doi.org/10.1681/ASN.2007060677
Joshua Y. Kausman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Richard Kitching
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading

Minimal-change disease (MCD) and primary FSGS are important causes of idiopathic nephrotic syndrome (INS) and, in the case of FSGS, end-stage renal failure. Intriguing features of these diseases include their frequent response to steroids, their association with immune abnormalities, the existence of a circulating permeability factor, and, in the case of FSGS, the tendency for disease to recur in some patients after transplantation. An article published in this issue of JASN1 shows that immune reconstitution of immunodeficient mice with cells from patients with INS induces a MCD-like lesion. This new story provides further evidence for INS being a disease of the immune system.

In 1974, Shalhoub2 proposed the now-famous hypothesis that “lipoid nephrosis,” what we now call MCD, is a disorder of T cell function resulting in the production of a circulating lymphokine toxin (later termed a vascular permeability factor) based on limited humoral immunity and immune effectors in glomeruli, remissions with measles infection or with corticosteroids and cyclophosphamide, and reports of disease occurring with Hodgkin's disease or thymoma. Although we now know more about INS, we still do not know how it occurs; neither do we have targeted, effective, and nontoxic therapies. We know that the podocyte, the primary glomerular cell type affected in INS, is critical to the maintenance of glomerular structure and function,3 and podocytes are directly affected by treatments for MCD/FSGS.4 Moreover, some cases of “idiopathic” FSGS are due to genetic mutations in podocyte-specific proteins.3 The recurrence of disease after transplantation, the control of posttransplantation FSGS with plasmapheresis or immunoabsorption, and the resolution of proteinuria after transplantation of nephrotic kidneys into recipients with ESRD that is not due to FSGS support the pathogenicity of this still-elusive circulating factor or factors.5

Given the association of MCD with allergy and atopy in children,6 it has been hypothesized that aberrant T helper cell 2 cytokine production drives this disease. Human podocytes express receptors for IL-4 and IL-13 and respond to either cytokine,7,8 and recent evidence in IL-13–overexpressing rats confirms IL-13 as a possible factor in MCD.9 Although disease has been associated with raised serum or peripheral blood mononuclear cell Th2 cytokines, not all studies are concordant.10 Assessment of immune abnormalities in patients with MCD and primary FSGS are confounded by the tendency of childhood relapses of MCD to be associated with viral infection, by questions of “cause versus consequence,”11 and by differences in methods of assessing cytokine production. Models of primary INS do exist. Transfer of supernatant from lymphocytes or T cell hybridomas of patients with nephrotic syndrome12 or a posttransplantation FSGS factor into rats results in proteinuria.13 The Buffalo/Mna rat strain develops nephrotic syndrome that is caused by immune abnormalities, perhaps with some additional intrarenal podocytic genetic abnormality.14,15

In this issue of JASN, Sellier-Leclerc et al.1 use an innovative approach, humanizing NOD/SCID mice, to implicate further an “immature” immune system in the pathogenesis of FSGS. Owing to severe combined immunodeficiency, these mice act as a “blank immunologic palette” into which human cells can be transplanted and engrafted and the resultant effects studied in vivo. Researchers have used these mice in studies of human lymphocyte development and HIV infection.16 Using human CD45 as a common leukocyte marker, immune cells from patients or control subjects were able to reconstitute an immune system in these mice to some degree. CD34 defines an immature cell population that has the capacity to differentiate into T cells, B cells, or myeloid cells. Transfer of immature CD34+ cells from patients with MCD or FSGS (but not control subjects) resulted in albuminuria and an MCD-like lesion in mice with electron microscopic–defined podocyte changes very similar to those seen in humans. The nature of the reconstitution was such that mature CD3+ cells were not seen in the periphery, counting against a mature T cell subset being culpable, and lack of regulatory T cell function also seemed unlikely.

Progenitor CD34+ cells differentiating into T lymphocytes are positively and negatively selected in the thymus. In humans, the T cell repertoire is most actively defined in early childhood, although T cell selection can occur throughout life. Data from other studies suggest that the dysregulated release of less than fully mature cells from the thymus is important in the pathogenesis if INS.17 The validity of humanizing SCID mice has been questioned, because human cells from a single donor that were transferred into syngeneic NOD/SCID mice led to engrafted populations with different T cell repertoires, explained by xenoreaction-driven selection.18 However, Sellier-Leclerc et al.1 report that despite using different human donors with INS, all successfully engrafted mice developed albuminuria and histologic changes, strengthening the case that this model is pertinent to the study of INS. The advantages of humanized in vivo systems have been detailed in other disease processes.19,20 This system, using human immune cells in vivo, may provide the means of defining the cellular and molecular immunopathogenesis of INS and perhaps will assist the development of more targeted interventions.

The induction of podocyte changes in a rodent does not in itself suggest pathogenetic relevance, but that these changes result from only transfer of patient cells is compelling evidence for immune dysregulation in MCD and primary FSGS. Refinement of this technically challenging model, for example by using strains of mice that lack both lymphocytes and NK cells (NOD/SCID/IL2Rγnull) yet develop normal lymph nodes will facilitate testing hypotheses that are generated by the discovery that immature cells may be the key.16 Is there a thymic abnormality, as suggested by some studies?17 Is there an immature T cell clonal proliferation in INS? Are any of the proposed soluble mediators, for example IL-13, important?7,9 Clearly, these studies do not rule out a key role for podocytes in defining disease severity or progression—maybe a combination of immune dysregulation and a “vulnerable podocyte” is required for resistant or progressive disease. Sellier-Leclerc et al.1 provide further support for a 33-yr-old hypothesis that has sounded attractive but has not been definitively proved. They answer some questions but raise others. Whether these findings will lead to more effective treatments is not clear, but they do add significantly to our understanding of these unusual and in some cases debilitating diseases.

Disclosures

None.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

    See the related article, “A Humanized Mouse Model of Idiopathic Nephrotic Syndrome Suggests a Pathogenic Role for Immature Cells,” on pages 2732–2739.

  • © 2007 American Society of Nephrology

References

  1. ↵
    Sellier-Leclerc A, Duval A, Riveron S, Macher M, Deschesnes G, Loirat C, Verpont M, Peuchmaur M, Ronco P, Monteiro R, Haddad E: Development of idiopathic nephrotic syndrome by humanizing NOD/SCID mice with patient cells demonstrates a role for immature cells. J Am Soc Nephrol 18 : 2732 –2739, 2007
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Shalhoub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2 : 556 –560, 1974
    OpenUrlCrossRefPubMed
  3. ↵
    Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13 : 3005 –3015, 2002
    OpenUrlFREE Full Text
  4. ↵
    Esposito C, Fornoni A, Cornacchia F, Bellotti N, Fasoli G, Foschi A, Mazzucchelli I, Mazzullo T, Semeraro L, Dal Canton A: Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int 58 : 123 –130, 2000
    OpenUrlCrossRefPubMed
  5. ↵
    Ali AA, Wilson E, Moorhead JF, Amlot P, Abdulla A, Fernando ON, Dorman A, Sweny P: Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation 58 : 849 –852, 1994
    OpenUrlCrossRefPubMed
  6. ↵
    Meadow SR, Sarsfield JK, Scott DG, Rajah SM: Steroid-responsive nephrotic syndrome and allergy: Immunological studies. Arch Intern Med 56 : 517 –524, 1981
    OpenUrl
  7. ↵
    Van Den Berg JG, Aten J, Chand MA, Claessen N, Dijkink L, Wijdenes J, Lakkis FG, Weening JJ: Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 11 : 413 –422, 2000
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Parry RG, Gillespie KM, Mathieson PW: Effects of type 2 cytokines on glomerular epithelial cells. Exp Nephrol 9 : 275 –283, 2001
    OpenUrlCrossRefPubMed
  9. ↵
    Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, Jordan SC, Yap HK: Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18 : 1476 –1485, 2007
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH: A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 21 : 603 –610, 2006
    OpenUrlCrossRefPubMed
  11. ↵
    Mathieson PW: Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 18[Suppl 6] : vi26 –vi29, 2003
    OpenUrl
  12. ↵
    Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40 : 453 –460, 1991
    OpenUrlCrossRefPubMed
  13. ↵
    Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP: Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330 : 7 –14, 1994
    OpenUrlCrossRefPubMed
  14. ↵
    Le Berre L, Godfrin Y, Gunther E, Buzelin F, Perretto S, Smit H, Kerjaschki D, Usal C, Cuturi C, Soulillou JP, Dantal J: Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 109 : 491 –498, 2002
    OpenUrlCrossRefPubMed
  15. ↵
    Le Berre L, Herve C, Buzelin F, Usal C, Soulillou JP, Dantal J: Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int 68 : 2079 –2090, 2005
    OpenUrlCrossRefPubMed
  16. ↵
    Legrand N, Weijer K, Spits H: Experimental models to study development and function of the human immune system in vivo. J Immunol 176 : 2053 –2058, 2006
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Mansour H, Cheval L, Elalouf JM, Aude JC, Alyanakian MA, Mougenot B, Doucet A, Deschenes G: T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney Int 67 : 2168 –2177, 2005
    OpenUrlCrossRefPubMed
  18. ↵
    Garcia S, Dadaglio G, Gougeon ML: Limits of the human-PBL-SCID mice model: Severe restriction of the V beta T-cell repertoire of engrafted human T cells. Blood 89 : 329 –336, 1997
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Mosier DE, Gulizia RJ, MacIsaac PD, Torbett BE, Levy JA: Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 260 : 689 –692, 1993
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Hope KJ, Jin L, Dick JE: Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5 : 738 –743, 2004
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 18 (10)
Journal of the American Society of Nephrology
Vol. 18, Issue 10
October 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
A New Approach to Idiopathic Nephrotic Syndrome
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A New Approach to Idiopathic Nephrotic Syndrome
Joshua Y. Kausman, A. Richard Kitching
JASN Oct 2007, 18 (10) 2621-2622; DOI: 10.1681/ASN.2007060677

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
A New Approach to Idiopathic Nephrotic Syndrome
Joshua Y. Kausman, A. Richard Kitching
JASN Oct 2007, 18 (10) 2621-2622; DOI: 10.1681/ASN.2007060677
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

UP FRONT MATTERS

  • Predicting Future Outcomes from Kidney Biopsies with MCD/FSGS Lesions: Opportunities and Limitations
  • Kidney Health Disparities: The Goal is Elimination
  • Autoimmune Renal Calcium and Magnesium Wasting
Show more UP FRONT MATTERS

Editorials

  • A Novel Pathological Mechanism of Tertiary Lymphoid Structure Formation in the Renal Pelvis
  • Disarming the Old Foe. Restoring T-Cell Immune Function with mTor-Inhibitors to Tackle Cytomegalovirus Infection
  • Genome-wide Admixture Mapping of eGFR and CKD Identify European and African Ancestry-of-Origin Loci in US Hispanics/Latinos
Show more Editorials

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • A Humanized Mouse Model of Idiopathic Nephrotic Syndrome Suggests a Pathogenic Role for Immature Cells
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire